These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2957702)

  • 21. Disseminating herpes simplex infection: primary lesions in urinary bladder and successful treatment with forscarnet sodium.
    Blohmé I; Ahlmén J; Jeansson S; Ranch T; Brynger H
    Transplant Proc; 1984 Dec; 16(6):1672-4. PubMed ID: 6239431
    [No Abstract]   [Full Text] [Related]  

  • 22. Assessment of phosphonoformate-treatment of pigeon herpesvirus infection in pigeons and budgerigars and Aujeszky's disease in rabbits.
    Vindevogel H; Pastoret PP; Aguilar-Setien A
    J Comp Pathol; 1982 Apr; 92(2):177-80. PubMed ID: 6282943
    [No Abstract]   [Full Text] [Related]  

  • 23. Tenofovir helps beat hepatitis B.
    TreatmentUpdate; 2003 Jan; 15(1):4. PubMed ID: 12630369
    [No Abstract]   [Full Text] [Related]  

  • 24. [Successful treatment with alpha-interferon of HBV and HDV coinfection. Case report of a 4-year-old boy].
    Pawłowska J; Burczyńska B; Kluge P; Socha J
    Pediatr Pol; 1995 May; 70(5):427-30. PubMed ID: 8692597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver transplantation of a HELLP syndrome donor liver in acute fulminant hepatitis B with deltavirus coinfection.
    Moussavian MR; Kollmar O; Richter S; Igna D; Schilling MK
    Transpl Int; 2006 Dec; 19(12):1030-1. PubMed ID: 17081235
    [No Abstract]   [Full Text] [Related]  

  • 26. Foscarnet and extended survival in AIDS patients.
    Am Fam Physician; 1991 Dec; 44(6):2244. PubMed ID: 1836090
    [No Abstract]   [Full Text] [Related]  

  • 27. Successful treatment with trisodium phosphonoformate for primary cytomegalovirus infection after heart transplantation.
    Locke TJ; Odom NJ; Tapson JS; Freeman R; McGregor CG
    J Heart Transplant; 1987; 6(2):120-2. PubMed ID: 3040944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Foscarnet for cytomegalovirus pneumonitis.
    Apperley JF; Marcus RE; Goldman JM; Wardle DG; Gravett PJ; Chanas A
    Lancet; 1985 May; 1(8438):1151. PubMed ID: 2860348
    [No Abstract]   [Full Text] [Related]  

  • 29. Foscarnet (phosphonoformate sodium) in the treatment of recurrent male genital herpes.
    Lim KB; Doraisingham S; Thirumoorthy T; Lee CT; Ling AE; Tan T
    Ann Acad Med Singap; 1986 Oct; 15(4):617-22. PubMed ID: 2952046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Fulminant hepatitis in a heroin addict caused by coinfection by B and delta viruses].
    Rodríguez M; García R; Pérez R; Rodrigo L
    Med Clin (Barc); 1985 Oct; 85(11):474. PubMed ID: 4068818
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical course of recurrent genital herpes and treatment with foscarnet cream: results of a Canadian multicenter trial.
    Sacks SL; Portnoy J; Lawee D; Schlech W; Aoki FY; Tyrrell DL; Poisson M; Bright C; Kaluski J
    J Infect Dis; 1987 Feb; 155(2):178-86. PubMed ID: 2949023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prophylaxis, Diagnosis and Therapy of Hepatitis-B-Virus-(HBV-)Infection: upgrade of the guideline, AWMF-Register 021/011].
    Cornberg M; Protzer U; Dollinger MM; Petersen J; Wedemeyer H; Berg T; Jilg W; Erhardt A; Wirth S; Schirmacher P; Fleig WE; Manns MP
    Z Gastroenterol; 2007 Jun; 45(6):525-74. PubMed ID: 17554641
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatitis D.
    Husa P; Linhartová A; Nemecek V; Husová L
    Acta Virol; 2005; 49(4):219-25. PubMed ID: 16402678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiviral effects of phosphonoformate (PFA, foscarnet sodium).
    Oberg B
    Pharmacol Ther; 1989; 40(2):213-85. PubMed ID: 2543994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Myelo-meningoradiculitis secondary to cytomegalovirus infection in a non immunocompromised patient. Treatment with foscarnet].
    Rogeaux O; Bedos JP; Wolf M; Vachon F
    Ann Med Interne (Paris); 1992; 143(3):219-20. PubMed ID: 1326248
    [No Abstract]   [Full Text] [Related]  

  • 36. Fulminant hepatitis B and delta virus coinfection in AIDS.
    Lichtenstein DR; Makadon HJ; Chopra S
    Am J Gastroenterol; 1992 Nov; 87(11):1643-7. PubMed ID: 1442692
    [No Abstract]   [Full Text] [Related]  

  • 37. First report of successful clearance of hepatitis B and D coinfection with tenofovir monotherapy.
    James G; Sidhu P; Raza M
    Hepatology; 2015 Jul; 62(1):317-8. PubMed ID: 25234819
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients.
    Ringdén O; Lönnqvist B; Paulin T; Ahlmén J; Klintmalm G; Wahren B; Lernestedt JO
    J Antimicrob Chemother; 1986 Mar; 17(3):373-87. PubMed ID: 3009383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Non-nucleoside antiherpetic agents].
    Nishiyama Y
    Nihon Rinsho; 1989 Feb; 47(2):390-4. PubMed ID: 2470934
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of HTLV-III/LAV replication by foscarnet.
    Sarin PS; Taguchi Y; Sun D; Thornton A; Gallo RC; Oberg B
    Biochem Pharmacol; 1985 Nov; 34(22):4075-9. PubMed ID: 2415134
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.